Product Images Simbrinza

SIMBRINZA is a sterile ophthalmic suspension that contains brinzolamide and brimonidine tartrate. It is used for the treatment of ocular hypertension and open-angle glaucoma. The suspension comes in a 10g bottle with a dosage strength of 1%/0.2%. The inactive ingredients include carbomer 974P, olopatadine HCl, sodium hydroxide, hydrochloric acid, and purified water. It is produced by Alcon Laboratories and should be stored between 12-25°C. The usual dosage should be determined by a healthcare provider.*

This appears to be a table of data from a study involving a medication called "SIMBRINZA" and two other medications, "Brinzolamide" and "Brim." The table shows a change of 10 mmHg in pressure (presumably intraocular pressure) for the treatment group (designated by "R") compared to the control group (designated by "G"). The data is displayed over a period of 3 months, with measurements taken at various times throughout the day. However, the table provides no context or explanation for the study or its results.*

This text appears to be a table containing information related to a study on an ophthalmic medication called "SIMBRINZA." The medication contains Brinzolamide and Brimonidine. The table shows changes in millimeters of mercury (mmHg) based on various time intervals (Week 2, Week 6, and Month 3) and times of day (BAM, 10AM, 3PM, 5PM, and 8AM). The meaning and context of the variables 'o' and 'b' is not clear.*